NCT00261430View on ClinicalTrials.gov

A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.

PHASE4CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2004

Conditions
Schizophrenia
Interventions
BEHAVIORAL

GAIN Acceptance Approach

All Listed Sponsors
lead

Janssen, LP

INDUSTRY